Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer’s disease via acetylcholinesterase inhibition and oxidative stress reduction. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.